Panbela Therapeutics Correlations

Summary

PBLADelisted Stock

USD 2.06 0.11 5.07%

The current 90-days correlation between Panbela Therapeutics and ZyVersa Therapeutics is -0.04 (i.e., Good diversification). The correlation of Panbela Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Panbela Therapeutics Correlation With Market

Significant diversification

The correlation between Panbela Therapeutics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Panbela Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Panbela Stock

0.81	DWTX	Dogwood Therapeutics, Symbol Change	Pair Corr
0.8	EMMA	Emmaus Life Sciences	Pair Corr
0.73	FNCH	Finch Therapeutics	Pair Corr
0.73	ENSCW	Ensysce Biosciences	Pair Corr
0.81	UPB	Upstream Bio,	Pair Corr
0.94	ZBIO	Zenas BioPharma, Common	Pair Corr
0.96	HRGN	Harvard Apparatus	Pair Corr
0.81	ZIVO	Zivo Bioscience	Pair Corr
0.84	KRBP	Kiromic Biopharma	Pair Corr
0.82	LADX	LadRx	Pair Corr
0.77	MTEM	Molecular Templates	Pair Corr
0.82	MTVA	MetaVia Symbol Change	Pair Corr
0.72	NAVB	Navidea Biopharmaceutica	Pair Corr
0.8	NEXI	Neximmune	Pair Corr

Moving against Panbela Stock

0.75	FBIOP	Fortress Biotech Pref	Pair Corr
0.74	FRTX	Fresh Tracks Therapeutics	Pair Corr
0.69	GRCE	Grace Therapeutics, Symbol Change	Pair Corr
0.61	VAXX	Vaxxinity	Pair Corr
0.6	EPRX	Eupraxia Pharmaceuticals	Pair Corr
0.38	CEROW	CERo Therapeutics Symbol Change	Pair Corr
0.35	EVLO	Evelo Biosciences	Pair Corr
0.92	LBPH	Longboard Pharmaceuticals	Pair Corr
0.84	LUMO	Lumos Pharma	Pair Corr
0.38	ABPWW	Abpro Holdings Symbol Change	Pair Corr

Related Correlations Analysis

	ZVSA	SONN	REVB	NAVB	CYTO	PALI	VRAX	QNRX	UNCY	CDIO
ZVSA		0.85	0.56	0.91	0.69	0.83	-0.01	0.41	-0.72	-0.53	ZVSA
SONN	0.85		0.77	0.84	0.83	0.95	-0.06	0.55	-0.84	-0.71	SONN
REVB	0.56	0.77		0.52	0.78	0.77	0.12	0.32	-0.75	-0.8	REVB
NAVB	0.91	0.84	0.52		0.73	0.88	-0.07	0.37	-0.7	-0.49	NAVB
CYTO	0.69	0.83	0.78	0.73		0.84	-0.11	0.4	-0.69	-0.61	CYTO
PALI	0.83	0.95	0.77	0.88	0.84		-0.07	0.46	-0.82	-0.72	PALI
VRAX	-0.01	-0.06	0.12	-0.07	-0.11	-0.07		-0.03	0.12	-0.01	VRAX
QNRX	0.41	0.55	0.32	0.37	0.4	0.46	-0.03		-0.19	-0.24	QNRX
UNCY	-0.72	-0.84	-0.75	-0.7	-0.69	-0.82	0.12	-0.19		0.79	UNCY
CDIO	-0.53	-0.71	-0.8	-0.49	-0.61	-0.72	-0.01	-0.24	0.79		CDIO
	ZVSA	SONN	REVB	NAVB	CYTO	PALI	VRAX	QNRX	UNCY	CDIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PALI	+ 0.95	SONN
NAVB	+ 0.91	ZVSA
PALI	+ 0.88	NAVB
SONN	+ 0.85	ZVSA
NAVB	+ 0.84	SONN
PALI	+ 0.84	CYTO

High negative correlations

UNCY	- 0.84	SONN
UNCY	- 0.82	PALI
CDIO	- 0.8	REVB
UNCY	- 0.75	REVB
CDIO	- 0.72	PALI
UNCY	- 0.72	ZVSA

Risk-Adjusted Indicators

There is a big difference between Panbela Stock performing well and Panbela Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Panbela Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	5.19	(0.39)	0.00	(0.11)	0.00	0.00	13.76	(8.06)	78.93
SONN	4.80	(1.48)	0.00	(2.57)	0.00	0.00	9.38	(12.92)	37.58
REVB	5.84	(0.43)	0.00	0.44	0.00	0.00	17.95	(8.82)	73.15
NAVB	6.04	(1.07)	0.00	0.63	0.00	0.00	12.50	(12.50)	40.40
CYTO	4.99	(2.10)	0.00	1.50	0.00	0.00	7.32	(10.87)	38.46
PALI	5.95	(0.75)	0.00	8.18	0.00	0.00	12.73	(12.26)	93.57
VRAX	7.20	0.86	0.11	(0.31)	6.65	(9.96)	21.39	(11.20)	70.25
QNRX	6.71	0.66	0.10	1.48	5.79	(10.75)	27.27	(9.59)	74.46
UNCY	4.53	0.85	0.14	0.62	4.68	(5.71)	14.00	(8.96)	29.86
CDIO	10.86	2.36	0.24	1.32	8.61	(16.75)	40.74	(15.12)	77.44

Panbela Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Panbela Therapeutics stock to make a market-neutral strategy. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics with similar companies.

ZyVersa Therapeutics Sonnet Biotherapeutics Holdings Revelation Biosciences Navidea Biopharmaceuticals Altamira Therapeutics Palisade Bio Virax Biolabs Group Quoin Pharmaceuticals Ltd Unicycive Therapeutics Cardio Diagnostics Holdings PaxMedica, Common Stock BWV Hillstream Biopharma Kiora Pharmaceuticals American Airlines Group

Risk & Return

Correlation

Panbela Therapeutics Corporate Executives

Elected by the shareholders, the Panbela Therapeutics' board of directors comprises two types of representatives: Panbela Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Panbela. The board's role is to monitor Panbela Therapeutics' management team and ensure that shareholders' interests are well served. Panbela Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Panbela Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Susan Horvath

CFO, Finance

Profile

Still Interested in Panbela Therapeutics?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC